Tricuspid Valve Surgery Outcomes Show Significant Improvement
Patient outcomes following tricuspid valve replacement (TVR) surgery have greatly improved over the past two decades, according to a recent study published in The Annals
Patient outcomes following tricuspid valve replacement (TVR) surgery have greatly improved over the past two decades, according to a recent study published in The Annals
LUMA Vision has received FDA clearance for its innovative Verafeye Visualization Platform, a catheter-based technology designed to enhance real-time imaging during interventional electrophysiology and structural
Anaconda Biomed has enrolled its first U.S. patient in the ATHENA clinical trial, marking a significant step in evaluating the effectiveness of its ANA Funnel
Lifeward (formerly ReWalk Robotics) has officially launched its next-generation ReWalk 7 personal exoskeleton in the United States, following FDA 510(k) clearance last month. The advanced
Johnson & Johnson (JNJ) revealed an anticipated $400 million in tariff costs for the year, contributing to a slight dip in shares, down nearly 1%
Stay ahead in MedTech with industry updates, breakthroughs, and expert
insights—delivered straight to your inbox.
© 2025 MEDWIRE.AI. All rights reserved. MEDWIRE.AI is a trusted source for MedTech news and insights. Our website content and services are for informational purposes only. MEDWIRE.AI does not provide medical advice, diagnosis, or treatment.
